Phase II, Open-Label Study of Pazopanib or Lapatinib Monotherapy Compared With Pazopanib Plus Lapatinib Combination Therapy in Patients With Advanced and Recurrent Cervical Cancer
Overview of attention for article published in Journal of Clinical Oncology, July 2010
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (91st percentile)
-
Good Attention Score compared to outputs of the same age and source (69th percentile)
Readers on
- mendeley
- 101 Mendeley